Neurogene (NGNE) Reports In-Line Q3 EPS

Neurogene (NASDAQ: NGNE) reported Q3 EPS of ($1.19), in-line with the analyst estimate of ($1.19).

For earnings history and earnings-related data on Neurogene (NGNE) click here.

You May Also Be Interested In

• ADP Employment Change (Aug) 38K vs 47K Expected
• Medtronic, Inc. (MDT) PT Raised to $95 at Stifel on Beat-and-Raise Quarter
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16